Literature DB >> 28831774

Humanized mice: models for evaluating NeuroHIV and cure strategies.

Jenna B Honeycutt1, J Victor Garcia2.   

Abstract

While the human immunodeficiency virus (HIV) epidemic was initially characterized by a high prevalence of severe and widespread neurological pathologies, the development of better treatments to suppress viremia over years and even decades has mitigated many of the severe neurological pathologies previously observed. Despite effective treatment, mild neurocognitive impairment and premature cognitive aging are observed in HIV-infected individuals, suggesting a changing but ongoing role of HIV infection in the central nervous system (CNS). Although current therapies are effective in suppressing viremia, they are not curative and patients must remain on life-long treatment or risk recrudescence of virus. Important for the development and evaluation of a cure for HIV will be animal models that recapitulate critical aspects of infection in vivo. In the following, we seek to summarize some of the recent developments in humanized mouse models and their usefulness in modeling HIV infection of the CNS and HIV cure strategies.

Entities:  

Keywords:  Antiretroviral therapy (ART); CNS; HIV/AIDS; Humanized mice; NeuroHIV

Mesh:

Substances:

Year:  2017        PMID: 28831774      PMCID: PMC6506160          DOI: 10.1007/s13365-017-0567-3

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  48 in total

1.  Loss of neuronal integrity during progressive HIV-1 infection of humanized mice.

Authors:  Prasanta K Dash; Santhi Gorantla; Howard E Gendelman; Jaclyn Knibbe; George P Casale; Edward Makarov; Adrian A Epstein; Harris A Gelbard; Michael D Boska; Larisa Y Poluektova
Journal:  J Neurosci       Date:  2011-03-02       Impact factor: 6.167

2.  Combined antiretroviral therapy reduces brain viral load and pathological features of HIV encephalitis in a mouse model.

Authors:  Rajeth Koneru; M Foster Olive; William R Tyor
Journal:  J Neurovirol       Date:  2014-01-11       Impact factor: 2.643

3.  Human immunodeficiency virus encephalitis in SCID mice.

Authors:  Y Persidsky; J Limoges; R McComb; P Bock; T Baldwin; W Tyor; A Patil; H S Nottet; L Epstein; H Gelbard; E Flanagan; J Reinhard; S J Pirruccello; H E Gendelman
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

4.  Neuroprotective activities of CEP-1347 in models of neuroAIDS.

Authors:  Dawn Eggert; Prasanta K Dash; Santhi Gorantla; Huanyu Dou; Giovanni Schifitto; Sanjay B Maggirwar; Stephen Dewhurst; Larisa Poluektova; Harris A Gelbard; Howard E Gendelman
Journal:  J Immunol       Date:  2009-12-04       Impact factor: 5.422

5.  Macrophages sustain HIV replication in vivo independently of T cells.

Authors:  Jenna B Honeycutt; Angela Wahl; Caroline Baker; Rae Ann Spagnuolo; John Foster; Oksana Zakharova; Stephen Wietgrefe; Carolina Caro-Vegas; Victoria Madden; Garrett Sharpe; Ashley T Haase; Joseph J Eron; J Victor Garcia
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808

6.  CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice.

Authors:  Barbara L Apostol; Danielle A Simmons; Chiara Zuccato; Katalin Illes; Judit Pallos; Malcolm Casale; Paola Conforti; Catarina Ramos; Margaret Roarke; Satish Kathuria; Elena Cattaneo; J Lawrence Marsh; Leslie Michels Thompson
Journal:  Mol Cell Neurosci       Date:  2008-04-24       Impact factor: 4.314

7.  Generation of HIV latency in humanized BLT mice.

Authors:  Paul W Denton; Rikke Olesen; Shailesh K Choudhary; Nancy M Archin; Angela Wahl; Michael D Swanson; Morgan Chateau; Tomonori Nochi; John F Krisko; Rae Ann Spagnuolo; David M Margolis; J Victor Garcia
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

8.  Macrophage infection via selective capture of HIV-1-infected CD4+ T cells.

Authors:  Amy E Baxter; Rebecca A Russell; Christopher J A Duncan; Michael D Moore; Christian B Willberg; Jose L Pablos; Andrés Finzi; Daniel E Kaufmann; Christina Ochsenbauer; John C Kappes; Fedde Groot; Quentin J Sattentau
Journal:  Cell Host Microbe       Date:  2014-11-20       Impact factor: 21.023

9.  A G1-like state allows HIV-1 to bypass SAMHD1 restriction in macrophages.

Authors:  Petra Mlcochova; Katherine A Sutherland; Sarah A Watters; Cosetta Bertoli; Rob Am de Bruin; Jan Rehwinkel; Stuart J Neil; Gina M Lenzi; Baek Kim; Asim Khwaja; Matthew C Gage; Christiana Georgiou; Alexandra Chittka; Simon Yona; Mahdad Noursadeghi; Greg J Towers; Ravindra K Gupta
Journal:  EMBO J       Date:  2017-01-25       Impact factor: 11.598

10.  HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy.

Authors:  Jenna B Honeycutt; William O Thayer; Caroline E Baker; Ruy M Ribeiro; Steven M Lada; Youfang Cao; Rachel A Cleary; Michael G Hudgens; Douglas D Richman; J Victor Garcia
Journal:  Nat Med       Date:  2017-04-17       Impact factor: 53.440

View more
  15 in total

Review 1.  Brain PET Imaging: Value for Understanding the Pathophysiology of HIV-associated Neurocognitive Disorder (HAND).

Authors:  Sanhita Sinharay; Dima A Hammoud
Journal:  Curr HIV/AIDS Rep       Date:  2019-02       Impact factor: 5.071

2.  Optimizing animal models for HIV-associated CNS dysfunction and CNS reservoir research.

Authors:  Jeymohan Joseph
Journal:  J Neurovirol       Date:  2018-03-26       Impact factor: 2.643

3.  Human Monocyte-Derived Macrophages (MDM): Model 2.

Authors:  Francesca Graziano; Elisa Vicenzi; Guido Poli
Journal:  Methods Mol Biol       Date:  2022

4.  T cells establish and maintain CNS viral infection in HIV-infected humanized mice.

Authors:  Jenna B Honeycutt; Baolin Liao; Christopher C Nixon; Rachel A Cleary; William O Thayer; Shayla L Birath; Michael D Swanson; Patricia Sheridan; Oksana Zakharova; Francesca Prince; JoAnn Kuruc; Cynthia L Gay; Chris Evans; Joseph J Eron; Angela Wahl; J Victor Garcia
Journal:  J Clin Invest       Date:  2018-06-04       Impact factor: 14.808

Review 5.  HIV-1 and drug abuse comorbidity: Lessons learned from the animal models of NeuroHIV.

Authors:  Susmita Sil; Annadurai Thangaraj; Ernest T Chivero; Fang Niu; Muthukumar Kannan; Ke Liao; Peter S Silverstein; Palsamy Periyasamy; Shilpa Buch
Journal:  Neurosci Lett       Date:  2021-03-29       Impact factor: 3.197

Review 6.  The Contributions of Clinical Pharmacology to HIV Cure Research.

Authors:  Courtney V Fletcher; Shetty Ravi Dyavar; Arpan Acharya; Siddappa N Byrareddy
Journal:  Clin Pharmacol Ther       Date:  2021-04-18       Impact factor: 6.903

7.  Persistent Viral Reservoirs in Lymphoid Tissues in SIV-Infected Rhesus Macaques of Chinese-Origin on Suppressive Antiretroviral Therapy.

Authors:  Summer Siddiqui; Stefanie Perez; Yong Gao; Lara Doyle-Meyers; Brian T Foley; Qingsheng Li; Binhua Ling
Journal:  Viruses       Date:  2019-01-27       Impact factor: 5.048

Review 8.  The HIV Reservoir in Monocytes and Macrophages.

Authors:  Michelle E Wong; Anthony Jaworowski; Anna C Hearps
Journal:  Front Immunol       Date:  2019-06-26       Impact factor: 7.561

9.  Human Interleukin-34 facilitates microglia-like cell differentiation and persistent HIV-1 infection in humanized mice.

Authors:  Saumi Mathews; Amanda Branch Woods; Ikumi Katano; Edward Makarov; Midhun B Thomas; Howard E Gendelman; Larisa Y Poluektova; Mamoru Ito; Santhi Gorantla
Journal:  Mol Neurodegener       Date:  2019-03-05       Impact factor: 14.195

10.  Development of a Novel In Vitro Primary Human Monocyte-Derived Macrophage Model To Study Reactivation of HIV-1 Transcription.

Authors:  Anna C Hearps; Anthony Jaworowski; Michelle E Wong; Chad J Johnson
Journal:  J Virol       Date:  2021-09-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.